ESCMID COVID-19 living guidelines: drug treatment and clinical management.

ABSTRACT:

Scope

In January 2021, the ESCMID Executive Committee decided to launch a new initiative to develop ESCMID guidelines on several COVID-19-related issues, including treatment of COVID-19.

Methods

An ESCMID COVID-19 guidelines task force was established by the ESCMID Executive Committee. A small group was established, half appointed by the chair, and the remaining selected with an open call. Each panel met virtually once a week. For all decisions, a simple majority vote was used. A long list of clinical questions using the PICO (population, intervention, comparison, outcome) format was developed at the beginning of the process. For each PICO, two panel members performed a literature search with a third panellist involved in case of inconsistent results. Voting was based on the

SUBMITTER: Bartoletti M 

PROVIDER: S-EPMC8606314 | biostudies-literature | 2022 Feb

REPOSITORIES: biostudies-literature